Rhythm Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.09.24	EWTX Yields Over 300% Returns, ADMA Records 200% Gains - Did You Strike While The Iron Is Hot? (RTTNews)
18.09.24	SLNO Skyrockets 800%, BWAY Blasts Past 400% - Were You On Board? (RTTNews)
26.08.24	Rhythm Pharma: FDA To Review Supplemental New Drug Application For IMCIVREE - Quick Facts (RTTNews)
04.01.24	Rhythm Pharma To Acquire Rights To Oral MC4R Agonist LB54640 From LG Chem (RTTNews)
15.09.22	Pre-market Movers: ATXG, FWBI, IDYA, ENOB, LUCY… (RTTNews)
06.09.22	Rhythm Pharmaceuticals Announces IMCIVREE® (setmelanotide) Granted Marketing Authorization by European Commission for Treatment of Obesity and Control of Hunger in Bardet-Biedl Syndrome (GlobeNewswire)
22.07.22	Rhythm Pharma: IMCIVREE Gets Positive CHMP Opinion For Obesity, Control Of Hunger In BBS Patients (RTTNews)
20.07.22	Rhythm Pharmaceuticals Announces Early Access Authorization for Setmelanotide for Use in Patients with Bardet-Biedl Syndrome in France (GlobeNewswire)
18.07.22	Rhythm Pharma: IMCIVREE Gets NICE Recommendation To Treat Obesity, Controlling Hunger (RTTNews)
17.06.22	Pre-market Movers: ADXN, FHTX, TBLT, TMDX, GP… (RTTNews)
17.06.22	FDA Approves Rhythm Pharma's Imcivree For Bardet-Biedl Syndrome, But Rejects For Alström Syndrome (RTTNews)
27.05.22	Biotech Stocks Facing FDA Decision In June 2022 (RTTNews)
15.10.21	Rhythm Pharmaceuticals schliesst die Einreichung des Antrags für die Typ-II-Variation für IMCIVREE ® (Setmelanotid) für Bardet-Biedl- und Alström-Syndrome bei der Europäischen Arzneimittelagentur ab (GlobeNewswire)
14.10.21	Rhythm Pharmaceuticals Completes Submission of Type II Variation Application to the European Medicines Agency for IMCIVREE® (setmelanotide) for Bardet-Biedl and Alström Syndromes (GlobeNewswire)
22.09.21	Rhythm Pharmaceuticals Presents New Data from Phase 2 and 3 Trials Evaluating Setmelanotide in Multiple Rare Genetic Diseases of Obesity at the 59th Annual ESPE Meeting (GlobeNewswire)
22.09.21	U.K. Approves Rhythm Pharma's Imcivree For Treatment Of Obesity And Control Of Hunger (RTTNews)
22.09.21	Rhythm Pharmaceuticals Announces Marketing Authorisation of IMCIVREE® (setmelanotide) in Great Britain (GlobeNewswire)
22.07.21	Rhythm Pharmaceuticals and Medison Pharma Partner to Commercialize IMCIVREE™ (setmelanotide) in Israel (GlobeNewswire)
21.05.21	Rhythm Pharma Receives Positive CHMP Opinion For Setmelanotide - Quick Facts (RTTNews)
21.05.21	Rhythm Pharmaceuticals Receives Positive CHMP Opinion for Setmelanotide for Treatment of Obesity and Control of Hunger Associated with POMC, PCSK1 and LEPR Deficiency (GlobeNewswire)
05.05.21	Rhythm Pharmaceuticals to Present at BofA Securities 2021 Virtual Health Care Conference (GlobeNewswire)
03.05.21	Rhythm Pharmaceuticals Reports First Quarter 2021 Financial Results (GlobeNewswire)
07.04.21	Rhythm Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
06.01.21	MRKR Soars As FDA Lifts Hold On MT-401, RYTM Sells Priority Review Voucher, MLND Dumps MLE-301 (RTTNews)
27.11.20	Stock Alert: Rhythm Pharma Shares Soar 15% On FDA Approval Of IMCIVREE (RTTNews)
27.11.20	Rhythm Pharma Announces FDA Approval Of IMCIVREE - Quick Facts (RTTNews)
22.11.20	Week Ahead In Pharma: EIGR Scripts History With Progeria Treatment, LQDA, RYTM Await FDA Decision (RTTNews)
26.10.20	Biotech Stocks Facing FDA Decision In November 2020 (RTTNews)
04.08.20	ALRN To Report Data In Q4, IMUC Hits New High, VYGR Pulls Out Of ABBV Deal, VNDA To Face FDA In Dec. (RTTNews)
21.09.19	Week Ahead In Pharma: 9 Stocks To Watch (AVXL, GMAB, ARAV…) (RTTNews)
05.10.18	This Day That Year: Rhythm Pharma (RTTNews)
22.06.18	XBIO Turns Heads, HRTX Hits New High, RYTM In Good Rhythm, SBOT On Watch (RTTNews)
19.06.18	CSBR Up 36% This Month, ZIOP Hit By Clinical Hold, Watch Out For SRPT Today (RTTNews)
03.04.18	RSLS Deflated, ALKS Depressed, ALNY On Watch (RTTNews)
13.03.18	FDA Places Clinical Hold On ADXS Study, ALT Proves A Good Shot, RYTM On Track (RTTNews)
09.01.18	WuXi NextCODE Artificial Intelligence Used to Advance Precision Therapy for Rare Genetic Disorders of Obesity (PR Newswire)
09.01.18	WuXi NextCODE Artificial Intelligence Used to Advance Precision Therapy for Rare Genetic Disorders of Obesity (PR Newswire)
14.11.17	Torque, a Flagship Pioneering Company, Launches Platform to Develop a New Class of Deep-Primed™ Immune Cell Therapies, Financed with $25M Series A and Led by a Veteran Management Team (PR Newswire)
17.10.17	HIIQ In Good Health, BOLD Awaits ASPIRO Data, CELESTIAL Lights Up EXEL (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Rhythm Pharmaceuticals Inc

Aktien Top/Flop

Meistgelesene Nachrichten